Literature DB >> 527207

Disposition and metabolism of bruceantin in the mouse.

W J Suling, C W Woolley, W M Shannon.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 527207     DOI: 10.1007/BF00262418

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


× No keyword cloud information.
  7 in total

1.  The isolation and structural elucidation of bruceantin and bruceantinol, new potent antileukemic quassinoids from Brucea antidysenterica.

Authors:  S M Kupchan; R W Britton; J A Lacadie; M F Ziegler; C W Sigel
Journal:  J Org Chem       Date:  1975-03-07       Impact factor: 4.354

2.  Mode of action of the antitumor compound bruceantin, an inhibitor of protein synthesis.

Authors:  L L Liao; S M Kupchan; S B Horwitz
Journal:  Mol Pharmacol       Date:  1976-01       Impact factor: 4.436

3.  CSTRIP, a fortran IV computer program for obtaining initial polyexponential parameter estimates.

Authors:  A J Sedman; J G Wagner
Journal:  J Pharm Sci       Date:  1976-07       Impact factor: 3.534

4.  Bruceantin, a new potent antileukemic simaroubolide from Brucea antidysenterica.

Authors:  S M Kupchan; R W Britton; M F Ziegler; C W Sigel
Journal:  J Org Chem       Date:  1973-01-12       Impact factor: 4.354

5.  New natural products of interest under development at the National Cancer Institute.

Authors:  J Douros; M Suffness
Journal:  Cancer Chemother Pharmacol       Date:  1978       Impact factor: 3.333

6.  Methods for detecting carcinogens and mutagens with the Salmonella/mammalian-microsome mutagenicity test.

Authors:  B N Ames; J Mccann; E Yamasaki
Journal:  Mutat Res       Date:  1975-12       Impact factor: 2.433

Review 7.  Types of anticancer agents isolated from plants.

Authors:  J L Hartwell
Journal:  Cancer Treat Rep       Date:  1976-08
  7 in total
  1 in total

1.  Clinical pharmacology of bruceantin by radioimmunoassay.

Authors:  K L Fong; D H Ho; R S Benjamin; N S Brown; A Bedikian; B S Yap; C L Wiseman; W Kramer; G P Bodey
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.